Overview

Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Pharmacokinetic/Pharmacodynamic Study of 3 Epoetin Alfa Formulations in Single Subcutaneous Doses Administered to Healthy Volunteers SPONSOR Biosidus S.A.
Phase:
Phase 1
Details
Lead Sponsor:
Bio Sidus SA
Treatments:
Epoetin Alfa